Literature DB >> 28598924

Resuscitative Endovascular Balloon Occlusion of the Aorta: Principles, Initial Clinical Experience, and Considerations for the Anesthesiologist.

Srikanth Sridhar1, Sam D Gumbert, Christopher Stephens, Laura J Moore, Evan G Pivalizza.   

Abstract

Resuscitative endovascular balloon occlusion of the aorta (REBOA) is an endovascular technique that allows for temporary occlusion of the aorta in patients with severe, life-threatening, trauma-induced noncompressible hemorrhage arising below the diaphragm. REBOA utilizes a transfemoral balloon catheter inserted in a retrograde fashion into the aorta to provide inflow control and support blood pressure until definitive hemostasis can be achieved. Initial retrospective and registry clinical data in the trauma surgical literature demonstrate improvement in systolic blood pressure with balloon inflation and improved survival compared to open aortic cross-clamping via resuscitative thoracotomy. However, there are no significant reports of anesthetic implications and perioperative management in this challenging cohort. In this narrative, we review the principles, technique, and logistics of REBOA deployment, as well as initial clinical outcome data from our level-1 American College of Surgeons-verified trauma center. For anesthesiologists who may not yet be familiar with REBOA, we make several suggestions and recommendations for intraoperative management based on extrapolation from these initial surgical-based reports, opinions from a team with increasing experience, and translated experience from emergency aortic vascular surgical procedures. Further prospective data will be necessary to conclusively guide anesthetic management, especially as potential complications and implications for global organ function, including cerebral and renal, are recognized and described.

Entities:  

Mesh:

Year:  2017        PMID: 28598924     DOI: 10.1213/ANE.0000000000002150

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  6 in total

Review 1.  [Resuscitative endovascular balloon occlusion of the aorta : Option for incompressible trunk bleeding?]

Authors:  J Knapp; M Bernhard; T Haltmeier; D Bieler; B Hossfeld; M Kulla
Journal:  Anaesthesist       Date:  2018-04       Impact factor: 1.041

2.  Comparison of Two Learning Modalities on Continuing Medical Education Consumption and Knowledge Acquisition: A Pilot Randomized Controlled Trial.

Authors:  Matthew D McEvoy; Leslie C Fowler; Amy Robertson; Brian J Gelfand; Geoffrey M Fleming; Bonnie Miller; Donald Moore
Journal:  J Educ Perioper Med       Date:  2021-07-01

3.  Resuscitative endovascular balloon occlusion of the aorta (REBOA): indications: advantages and challenges of implementation in traumatic non-compressible torso hemorrhage.

Authors:  Omar Bekdache; Tiffany Paradis; Yu Bai He Shen; Aly Elbahrawy; Jeremy Grushka; Dan Deckelbaum; Kosar Khwaja; Paola Fata; Tarek Razek; Andrew Beckett
Journal:  Trauma Surg Acute Care Open       Date:  2019-04-15

4.  Prophylactic temporary abdominal aortic balloon occlusion for patients with pernicious placenta previa: a retrospective study.

Authors:  Fei Huo; Hansheng Liang; Yi Feng
Journal:  BMC Anesthesiol       Date:  2021-04-29       Impact factor: 2.217

5.  Feasibility of basic transesophageal echocardiography in hemorrhagic shock: potential applications during resuscitative endovascular balloon occlusion of the aorta (REBOA).

Authors:  William A Teeter; Bianca M Conti; Phil J Wasicek; Jonathan J Morrison; Dawn Parsell; Bryan Gamble; Melanie R Hoehn; Thomas M Scalea; Samuel M Galvagno
Journal:  Cardiovasc Ultrasound       Date:  2018-07-16       Impact factor: 2.062

6.  Prophylactic endovascular balloon occlusion of the aorta in cases of placenta accreta spectrum during caesarean section: points from the anaesthesiologist's perspective.

Authors:  Haijuan Zhu; Shengyou Wang; Jingfa Shi; Lamei Yao; Li Wang; Hongbo Chen; Xiangdong Fang
Journal:  BMC Pregnancy Childbirth       Date:  2020-08-05       Impact factor: 3.007

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.